fig1

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Figure 1. Spectrum of cardio-nephro-metabolic and vascular manifestations of MASLD[32-36]. AF: atrial fibrillation; CVD: cardiovascular disease; HF: heart failure; HTN: arterial hypertension; MASLD: metabolic dysfunction-associated steatotic liver disease.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/